R&D News | pharmaphorum

News

scientifically visualization of a coronavirus spike protein

Lilly takes AI-selected Olumiant into phase 3 for COVID-19

Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis drug Olumiant as a treatment for people with COVID-19.

News

teenager buying drug at club during spring break party

Evidence builds for use of MDMA as PTSD therapy

MDMA has become notorious as an illegal dance drug – but the evidence supporting its approval as a treatment for post-traumatic stress disorder (PTSD) in combination with psychotherapy is m

News

UK's Imperial College begins trial of coronavirus vaccine

Researchers from Imperial College London have begun clinical trials of a new coronavirus vaccine, backed by funding from the UK government and philanthropic donations.

News

'Major breakthrough' as cheap steroid cuts deaths in COVID-1...

The answer to improving survival rates in people with severe respiratory complications caused by COVID-19 is a generic steroid drug that can be bought for a few pounds.

News

hydroxychloroquine sulphate tablets, in evaluation for treatment of COVID-19.Denmark, Mars 22, 2020

UK stops recruitment to hydroxychloroquine COVID-19 trials

The UK's drugs regulator has suspended recruitment to COVID-19 trials involving the drug hydroxychloroquine, saying that a review of study data did not provide evidence of any meaningful mo

News

Novo Nordisk diversifies with $2.1bn deal to buy Corvidia

Novo Nordisk has taken another step towards expanding beyond its heartlands of diabetes and obesity with a deal to buy US biotech Corvidia Therapeutics and its lead drug for ch

Lilly takes AI-selected Olumiant into phase 3 for COVID-19

Evidence builds for use of MDMA as PTSD therapy

UK's Imperial College begins trial of coronavirus vaccine

'Major breakthrough' as cheap steroid cuts deaths in COVID-1...

UK stops recruitment to hydroxychloroquine COVID-19 trials

Novo Nordisk diversifies with $2.1bn deal to buy Corvidia

Lilly inflates US facility investment spending by $4.5bn

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks